Wednesday, October 01, 2014 11:44:36 PM
Because your thinking follows a robotic script that is usually dead-on here on the OTC.
But there are always exceptions, however rare, to these rules -- and in the MJ sector, TRTC is THE EXCEPTION.
Your typical penny stock script failed when TRTC moved from .06 to $1.42 even under the threat of Hanover's dilution.
And history will repeat itself once again because...
I am Sleek and you are not.
Therefore, you lack SleekVISION and I, well, don't...
Sleek
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM